United States · 
Who invested in Aro Biotherapeutics?
Aro Biotherapeutics's investors include Northpond Ventures.
United States · Series B startup
Who invested in Aro Biotherapeutics
Funding summaryUpdated 26 Oct 2026
$42Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $42MNov 2023
- Investors
- 1
The rounds
- Nov 2023
Founders and team
From the SEC filings it signed: 5 on the team.
- Karyn B O'NeilExecutive Officer, Directori
- Mark B LaurenziExecutive Officeri
- Mittie B DoyleExecutive Officeri
- Scott B GreenbergExecutive Officeri
- Susan B DillonExecutive Officer, Directori
On the board, as filediBruce B PeacockChristopher B MirabelliDaniel B JanseElizabeth B AndersonKevin B RaidyMarten B Steen
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Aro Biotherapeutics
How much has Aro Biotherapeutics raised?
Aro Biotherapeutics has raised $42M across 1 round since 2023.
When did Aro Biotherapeutics last raise?
Aro Biotherapeutics's most recent round was a Series B of $42M in Nov 2023.
What was Aro Biotherapeutics's biggest round?
Its most recent round, $42M in Nov 2023, is also its largest on record.
Who backed Aro Biotherapeutics first?
Aro Biotherapeutics's first round on record, in Nov 2023, was backed by Northpond Ventures.
What stage is Aro Biotherapeutics at?
Aro Biotherapeutics's latest named round is a Series B, in Nov 2023.
Where is Aro Biotherapeutics based?
Aro Biotherapeutics is based in the United States.
Companies like Aro Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.